American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$510M |
| 2 |
ExxonMobil
XOM
|
+$222M |
| 3 |
Apple
AAPL
|
+$199M |
| 4 |
CRH
CRH
|
+$189M |
| 5 |
Meta Platforms (Facebook)
META
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$387M |
| 2 |
Colgate-Palmolive
CL
|
+$242M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$183M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.59% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
NerdWallet
NRDS
$639M
| $287K | ﹤0.01% |
19,691
-14,341
| -42% | -$197K |
|
2602
NETSCOUT
NTCT
$2.89B
| $287K | ﹤0.01% |
+15,673
| New | +$309K |
|
2603
Dave Inc
DAVE
$4.26B
| $284K | ﹤0.01% |
9,386
+3,491
| +59% | +$142K |
|
|
AMPS
2604
DELISTED
Altus Power
AMPS
| $284K | ﹤0.01% |
72,322
+9,062
| +14% | +$37.7K |
|
|
CMLS
2605
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $283K | ﹤0.01% |
138,545
-24,624
| -15% | -$63.9K |
|
|
HCP
2606
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $283K | ﹤0.01% |
+8,388
| New | +$261K |
|
2607
Choiceone Financial
COFS
$515M
| $282K | ﹤0.01% |
9,827
-100
| -1% | -$2.55K |
|
2608
E.W. Scripps
SSP
$310M
| $280K | ﹤0.01% |
89,180
+13,156
| +17% | +$41.7K |
|
2609
Magnachip Semiconductor
MX
$137M
| $278K | ﹤0.01% |
57,173
+6,777
| +13% | +$34.1K |
|
2610
Bank7 Corp
BSVN
$499M
| $278K | ﹤0.01% |
8,876
| – | – |
|
2611
TScan Therapeutics
TCRX
$52.3M
| $278K | ﹤0.01% |
47,481
+15,596
| +49% | +$123K |
|
2612
Lakeland Industries
LAKE
$117M
| $277K | ﹤0.01% |
12,071
-21,902
| -64% | -$412K |
|
2613
Canadian Solar
CSIQ
$1.04B
| $276K | ﹤0.01% |
18,716
+1,383
| +8% | +$23.4K |
|
2614
J. Jill
JILL
$283M
| $268K | ﹤0.01% |
7,676
+930
| +14% | +$28.5K |
|
2615
4D Molecular Therapeutics
FDMT
$609M
| $268K | ﹤0.01% |
+12,787
| New | +$321K |
|
|
HTT
2616
High Templar Tech Ltd
HTT
$391M
| $268K | ﹤0.01% |
135,158
+4,627
| +4% | +$9.65K |
|
|
PSTX
2617
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $264K | ﹤0.01% |
90,487
+5,023
| +6% | +$13.7K |
|
|
DAY
2618
DELISTED
Dayforce
DAY
| $264K | ﹤0.01% |
5,324
| – | – |
|
2619
CryoPort
CYRX
$766M
| $264K | ﹤0.01% |
38,204
-14,898
| -28% | -$201K |
|
2620
Outdoor Holding Co
POWW
$255M
| $264K | ﹤0.01% |
157,016
+39,736
| +34% | +$95.6K |
|
2621
Atlanta Braves Holdings Series A
BATRA
$3.64B
| $261K | ﹤0.01% |
6,306
-2,740
| -30% | -$113K |
|
2622
Talkspace
TALK
$871M
| $260K | ﹤0.01% |
112,973
-7,357
| -6% | -$21.2K |
|
2623
AngioDynamics
ANGO
$647M
| $259K | ﹤0.01% |
42,758
+926
| +2% | +$5.71K |
|
2624
Omega Flex
OFLX
$291M
| $257K | ﹤0.01% |
5,006
+1,673
| +50% | +$107K |
|
2625
Inovio Pharmaceuticals
INO
$93M
| $255K | ﹤0.01% |
31,565
+12,100
| +62% | +$127K |
|
Similar funds
American Century Companies's Q2 2024 Portfolio in Review
As of Q2 2024, American Century Companies held 3,009 positions worth $163B, up 2.7% from $159B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
American Century Companies's Q2 2024 filing shows 89 new, 1,863 increased, 760 reduced and 131 closed positions. Its largest new stake was UL Solutions: 1,631,475 shares worth $68.8M. The largest sale was UnitedHealth, an estimated $387M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2024 buy was UL Solutions: 1,631,475 shares worth $68.8M.
- American Century Companies added most to iShares Russell 1000 Growth ETF in Q2 2024, an estimated $510M increase.
- American Century Companies's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $387M.
- American Century Companies fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $235M.
- American Century Companies's ten largest holdings make up 27% of its $163B portfolio in Q2 2024.
- American Century Companies opened 89 new positions and closed 131 in Q2 2024.
- American Century Companies's portfolio value rose 2.7% quarter-over-quarter to $163B.
Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.